These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7515129)

  • 1. Effects of guanidino and uremic compounds on nitric oxide pathways.
    MacAllister RJ; Whitley GS; Vallance P
    Kidney Int; 1994 Mar; 45(3):737-42. PubMed ID: 7515129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of some guanidino compounds on human cerebral arteries.
    Segarra G; Medina P; Ballester RM; Lluch P; Aldasoro M; Vila JM; Lluch S; Pelligrino DA
    Stroke; 1999 Oct; 30(10):2206-10; discussion 2210-11. PubMed ID: 10512930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide formation by guanidines.
    Hasan K; Heesen BJ; Corbett JA; McDaniel ML; Chang K; Allison W; Wolffenbuttel BH; Williamson JR; Tilton RG
    Eur J Pharmacol; 1993 Nov; 249(1):101-6. PubMed ID: 7506664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
    Griffiths MJ; Messent M; MacAllister RJ; Evans TW
    Br J Pharmacol; 1993 Nov; 110(3):963-8. PubMed ID: 7507781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.
    Kilpatrick EV; Cocks TM
    Br J Pharmacol; 1994 Jun; 112(2):557-65. PubMed ID: 7521260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
    Bedarida GV; Kim D; Blaschke TF; Hoffman BB
    Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
    Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
    Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.
    MacAllister RJ; Parry H; Kimoto M; Ogawa T; Russell RJ; Hodson H; Whitley GS; Vallance P
    Br J Pharmacol; 1996 Dec; 119(8):1533-40. PubMed ID: 8982498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.
    Schlemper V; Calixto JB
    Br J Pharmacol; 1994 Jan; 111(1):83-8. PubMed ID: 8012728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA; Ayres M; Chelly F; Kilbourn RG
    Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus.
    Al-Zobaidy MJ; Martin W
    Eur J Pharmacol; 2014 Oct; 741():171-7. PubMed ID: 25149663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization.
    Rand VE; Garland CJ
    Br J Pharmacol; 1992 May; 106(1):143-50. PubMed ID: 1380379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum.
    Osthaus LE; Galligan JJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):140-5. PubMed ID: 1370537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
    Rees DD; Palmer RM; Hodson HF; Moncada S
    Br J Pharmacol; 1989 Feb; 96(2):418-24. PubMed ID: 2924084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.